Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Projecten
- 2 Afgelopen
-
ANI400: De evaluatie van AXL-specifieke antilichamen met één domein als diagnostische tracer en voor therapeutische toepassing bij acute myeloïde leukemie
De Veirman, K. (Administrative Promotor) & Vandewalle, N. (CoI (Co-Promotor))
1/11/24 → 30/04/25
Project: Fundamenteel
-
FWOSB110: Inhibitie van AXL met behulp van Nanobodies met als doel het immuunsysteem te activeren en chemotherapie respons te verhogen in Acute Myeloide Leukemie.
Vandewalle, N. (Administrative Promotor) & De Veirman, K. (Administrative Promotor)
1/11/20 → 31/10/24
Project: Fundamenteel
-
AXL-Specific Single-Domain Antibodies: A Novel Diagnostic and Therapeutic Strategy in PDAC
Denis, A., Michiels, E., Baldan, J., Satilmis, H., Zhan, D., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N., Rooman, I. & De Veirman, K., 6 feb. 2026. 1 blz.Onderzoeksoutput: Poster
-
AXL-erating the fight: Conquering acute myeloid leukemia with single domain antibodies
Vandewalle, N., 2025, 186 blz.Onderzoeksoutput: PhD Thesis
-
Activated cDCs by anti-CD40 agonist therapy induce anti-tumor effectsin Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2024, (Unpublished).Onderzoeksoutput: Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 30 mei 2024, (Unpublished).Onderzoeksoutput: Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 1 feb. 2024, (Unpublished).Onderzoeksoutput: Poster
Datasets
-
Dataset of AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N. (Creator), Satilmis, H. (Creator), Verheye, E. (Creator), Wang, Y. (Creator), De Groof, T. (Creator), Bridoux, J. (Creator), Kerre, T. (Creator), De Beule, N. (Creator), De Becker, A. (Creator), De Bruyne, E. (Creator), Menu, E. (Creator), Vanderkerken, K. (Creator), Breckpot, K. (Creator), Devoogdt, N. (Creator) & De Veirman, K. (Creator), Theranostics, 15 apr. 2024
DOI: 10.7150/thno.91456, https://zenodo.org/records/15111364
Dataset
-
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages
Laoui, D. (Creator), Kancheva, D. (Creator), Satilmis, H. (Creator), Vandewalle, N. (Creator), Fan, R. (Creator), Bardet, P. (Creator), Clappaert, E. (Creator), Verstaen, K. (Creator), De Becker, A. (Creator), Vanderkerken, K. (Creator) & De Veirman, K. (Creator), NCBI Gene Expression Omnibus, 14 nov. 2024
Dataset
Prijzen
-
Best Poster Presentation
Vandewalle, N. (Recipient), Menu, E. (Recipient), De Bruyne, E. (Recipient), De Veirman, K. (Recipient), Breckpot, K. (Recipient) & Devoogdt, N. (Recipient), 2 feb. 2024
Prijs: Prize (including medals and awards)
Activiteiten
-
AXL-specific Single-Domain Antibodies Modulate the Immune Microenvironment and Enhance Checkpoint Blockade in AML
Zhan, D. (Presenter), Vandewalle, N. (Contributor), Satilmis, H. (Contributor), Verheye, E. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
25 sep. 2025Activiteit: Talk or presentation at a conference
-
PhD Day of the LSM Doctoral School
Geirnaert, F. (Chair), Wyns, A. (Chair) & Vandewalle, N. (Chair)
26 mrt. 2024Activiteit: Participation in conference
-
Charity Quiz 2024
Vandewalle, N. (Chair), Wyns, A. (Chair) & Geirnaert, F. (Chair)
6 dec. 2024Activiteit: Participating in or organizing a school event
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N. (Presenter), Satilmis, H. (Contributor), Verheye, E. (Contributor), Wang, Y. (Contributor), De Groof, T. (Contributor), De Beule, N. (Contributor), kerre, T. (Contributor), De Beule, N. (Contributor), De Becker, A. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
12 mrt. 2024Activiteit: Talk or presentation at a conference
-
Charity Quiz PhD United 2023
Vandewalle, N. (Organiser), Geirnaert, F. (Organiser), Wyns, A. (Organiser), Muylaert, C. (Organiser), Walckiers, J. (Organiser), Lobo, M. (Organiser), Vanonckelen, O. (Organiser), Van Hemelrijck, L. A. (Organiser), Van Campenhout, J. (Organiser), Van der Vliet, M. (Organiser), Hanssens, H. (Organiser), Janssens, C. (Organiser), De Coster, M. (Organiser), Van den Bossche, J.-L. (Organiser) & Coolens, K. (Organiser)
14 dec. 2023Activiteit: Participating in or organizing a school event
Scriptie
-
Targeting AXL, by small molecule inhibitors and Nanobody-based approaches, to eliminate cancer cells and improve chemotherapeutic responses in Acute Myeloid Leukemia
De Veirman, K. (Promotor), Devoogdt, N. (Co-promotor), Breckpot, K. (Co-promotor) & Vandewalle, N. ((PhD) Student), 18 jun. 2020Scriptie/Masterproef: Master's Thesis